Skip to content

Safety confirmation test of collagen-containing food

Safety confirmation test of collagen-containing food - Safety confirmation test of collagen-containing food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041495
Enrollment
22
Registered
2021-08-15
Start date
2020-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (healthy adults)

Interventions

Collagen-containing food, 4 weeks excessive consumption

Sponsors

Oneness support Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Healthy adult males and females aged 20 to 74 years-old (2)Those whose written informed consent have been obtained

Exclusion criteria

Exclusion criteria: (1)Those who have a history of diabetes, liver disease, kidney disease, digestive system disease, heart disease, or other diseases that may affect the results of this test, or who have had a history of surgery (2)Those with abnormal liver and renal function test values (3)Those who have a disease currently being treated (4)Those with anemia (5)Those who detect abnormal values by blood test (6)Those with food and drug allergies (7)Those who play intense sports and who are on a diet (8)Those who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and designated quasi-drugs during the test period (9)Those who continuously take medicines (including OTC and prescription medicines) (10)Those who have taken the blood sampling more than 200 mL within 1 month, or plan the blood sampling during the study period (11)Heavy drinkers, or those who can't stop drinking from the day before the test until the day (12)Those who have smoking habits (13)Those with irregular life patterns and with lifestyle of reversal of day and night (14)Those who have habits of excessive eating and drinking (15)Those who have been pregnant or those who have a plan to become pregnant or breast feed during the study period (16)Those who are participating in or will be participating in other clinical trials at the start of this study, and those within 4 weeks after the end (17)Those who judged that examination responsible doctor is not appropriate for this study participation

Design outcomes

Primary

MeasureTime frame
Doctor's questions, Physiological test, Clinical examination, Adverse event

Countries

Japan

Contacts

Public ContactMegumi Takahashi

Ryusendo Co., Ltd. Development Division

m.takahashi@ryusendo.co.jp03-3985-8346

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026